Audientes AS is a Danish hearing technology company specializing in smart, self-fitting, and affordable hearing aids. Audientes’ hearing aid solutions portfolio comprises Ven, a self-fitting, binaural hearing aid designed for individuals with severe to profound hearing loss in one or both ears, and Companion, a hearable that doubles as a premium Bluetooth headset, designed for individuals seeking enhanced hearing in specific situations. It offers crystal-clear sound, natural speech clarity, and Bluetooth connectivity for calls and media streaming.
2014
8
LTM Revenue n/a
LTM EBITDA n/a
$1.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Audientes has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Audientes achieved revenue of $0.3M and an EBITDA of -$0.8M.
Audientes expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Audientes valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $0.4M | $0.3M | XXX | XXX | XXX |
Gross Profit | -$0.7M | -$0.3M | XXX | XXX | XXX |
Gross Margin | -164% | -111% | XXX | XXX | XXX |
EBITDA | -$1.2M | -$0.8M | XXX | XXX | XXX |
EBITDA Margin | -306% | -326% | XXX | XXX | XXX |
Net Profit | -$3.7M | -$2.0M | XXX | XXX | XXX |
Net Margin | -916% | -789% | XXX | XXX | XXX |
Net Debt | n/a | $0.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 13, 2025, Audientes's stock price is DKK 0 (or $0).
Audientes has current market cap of DKK 8.2M (or $1.2M), and EV of DKK 11.2M (or $1.7M).
See Audientes trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.7M | $1.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 13, 2025, Audientes has market cap of $1.2M and EV of $1.7M.
Audientes's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Audientes's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Audientes and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $1.7M | XXX | XXX | XXX |
EV/Revenue | 6.6x | XXX | XXX | XXX |
EV/EBITDA | -2.0x | XXX | XXX | XXX |
P/E | -0.8x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -1.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAudientes's NTM/LTM revenue growth is n/a
Audientes's revenue per employee for the last fiscal year averaged $32K, while opex per employee averaged n/a for the same period.
Over next 12 months, Audientes's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Audientes's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Audientes and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -36% | XXX | XXX | XXX | XXX |
EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
EBITDA Growth | -32% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | N/A | XXX | XXX | XXX | XXX |
Revenue per Employee | $32K | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 5% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Audientes acquired XXX companies to date.
Last acquisition by Audientes was XXXXXXXX, XXXXX XXXXX XXXXXX . Audientes acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Audientes founded? | Audientes was founded in 2014. |
Where is Audientes headquartered? | Audientes is headquartered in Sweden. |
How many employees does Audientes have? | As of today, Audientes has 8 employees. |
Is Audientes publicy listed? | Yes, Audientes is a public company listed on SAT. |
What is the stock symbol of Audientes? | Audientes trades under AUDNTS ticker. |
When did Audientes go public? | Audientes went public in 2022. |
Who are competitors of Audientes? | Similar companies to Audientes include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
What is the current market cap of Audientes? | Audientes's current market cap is $1.2M |
What is the current revenue growth of Audientes? | Audientes revenue growth between 2023 and 2024 was -36%. |
Is Audientes profitable? | Yes, Audientes is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.